Emerging World Pharma Inc. is an investor in generic based pharmaceutical companies manufacturing within developing nations. Emerging World Pharma Inc. is unique in that it is focused on companies that assist developing nations to become self-sufficient in their medicine needs through the introduction of advanced production infrastructure, the hiring and training of local employees and the use of top quality raw materials.
The demand for medicine in developing nations is immense. Counterfeit medicines and unreliable medicine supply systems continue to impede access for these nations. Emerging World Pharma Inc. sees local pharmaceutical production as the future of the generic pharmaceutical industry because of the numerous benefits to both the pharmaceutical manufacturers and the nations that they operate in. The benefits of local production to the pharmaceutical manufacturing companies include: lowered production costs, reduced shipping demands and less stringent regulation. Some of the benefits of local production to the developing nations include: the reduction of foreign exchange costs, local job creation, promotion of social development and technology transfer facilitation.
In-depth market research is conducted to ensure that Emerging World Pharma Inc. invests in pharmaceutical companies that manufacture within nations that meet requirements of political and economic stability. Through this rigorous screening process and continual analysis of market viability, Emerging World Pharma Inc. is able to ensure a healthy return on investment.
Emerging World Pharma Inc.’s management team has international experience in growth-oriented technology, business unit development, finance, medicine and pharmaceutical manufacturing.
|
